Wave Life Sciences
7.54
Open
Market Cap
High
Low
Close
Volume
P/E Ratio
Div/Yield
About Wave Life Sciences
Wave Life Sciences Ltd. was incorporated in Singapore on July 23, 2012. The company is a clinical-stage biotechnology firm dedicated to harnessing the broad potential of RNA therapeutics—also known as oligonucleotides—or targeted ribonucleic acid (RNA) to transform human health. Leveraging its RNA therapeutic platform, PRISMTM, Wave Life Sciences combines multiple modalities, chemical innovations, and deep insights into human genetics to deliver scientific breakthroughs aimed at treating both rare and prevalent diseases. The company’s RNA-targeting toolkit includes RNA editing, splicing modulation, antisense silencing, and RNA interference (RNAi), providing a unique ability to design and sustainably deliver optimal drug candidates that address complex disease biology. Wave Life Sciences is spearheading programs targeting both rare and common conditions such as alpha-1 antitrypsin deficiency (AATD), obesity, Duchenne muscular dystrophy (DMD), and Huntington’s disease (HD). For more information, visit their website at http://www.wavelifesciences.com. Their corporate headquarters is located at 7 Straits View #12-00, Marina One East Tower, Singapore 018936.
Trade GPT
Similar Stocks
© 2025 Rockalpha Limited. All Rights Reserved.
Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider. Rockalpha Limited is not licensed by a New Zealand regulator to provide the client money or property services, and Rockalpha Limited’s registration on the New Zealand register of financial service providers or membership of the Insurance & Financial Services Ombudsman Scheme does not mean that Rockalpha Limited is subject to active regulation or oversight by a New Zealand regulator.Rockalpha Limited is registered on the New Zealand Financial Service Providers Register(FSP: 1001454). Rockalpha Limited's Financial Service Providers registration can be verified on the Financial Service Providers Register. Rockalpha Limited is a member of the Insurance & Financial Services Ombudsman Scheme, an independent dispute resolution service provider.
Rockalpha Limited, operates from its Singapore headquarters at CapitaSky 808, 79 Robinson Road, Singapore 068897, with a regional office at Level 6, Core C, Cyberport 3, 100 Cyberport Road, Hong Kong.